Should You Add Dexamethasone Before IVF Transfer?

The clinical evidence, however, does not support a simple rule that a slightly abnormal immune result means a steroid should be added.

A Cochrane review of glucocorticoids around implantation in assisted reproductive technology found that the evidence was low to very low quality. The main limitations were poor reporting of study methods and small study sizes, and the review concluded that more research is needed to identify which, if any, patient groups may benefit.

The American Society for Reproductive Medicine, or ASRM, reached a similar practical conclusion in its IVF immunotherapy guideline. It summarized a systematic review and meta-analysis of 14 randomized trials involving 1,879 couples and found no clear evidence that peri-implantation glucocorticoids significantly improved clinical outcomes. The studies also varied widely in drug choice, dose, timing and patient selection.

So the most useful framing is this: dexamethasone is not necessarily off the table, but it should not be added just because one immune number is high. It is better treated as a targeted, short-term and monitored prescription decision.

Why fertility doctors consider dexamethasone

Dexamethasone is a synthetic, long-acting glucocorticoid. Literature on recurrent embryo implantation failure describes its duration of action as about 36 to 54 hours, with immune-suppressing, anti-inflammatory and anti-allergic effects.

In reproductive medicine, glucocorticoids have been proposed as a way to alter immune signalling in the endometrium, including inflammation, uterine natural killer cell activity and cytokine expression. The challenge is that a biologically plausible mechanism does not automatically translate into better pregnancy outcomes.

ASRM notes that the available studies are difficult to apply broadly because they used different steroid medications, doses, schedules and inclusion criteria. In everyday terms, one clinic’s short course of dexamethasone before transfer may not be comparable with another study’s prednisone, hydrocortisone or methylprednisolone protocol.

When the conversation may be more reasonable

Dexamethasone is more worth a careful discussion when there is a broader clinical pattern, not just a one-off blood test result. Examples include:

• several unsuccessful transfers of good-quality embryos;
• a history that has reached the point where recurrent implantation failure, or RIF, is being evaluated;
• repeated immune or inflammatory findings that fit the clinical picture;
• a doctor who can explain the specific problem the steroid is meant to address;
• a written plan for when to start, when to stop, what happens if the pregnancy test is positive, and how blood sugar, blood pressure and infection symptoms will be monitored.

The European Society of Human Reproduction and Embryology, or ESHRE, recommends against defining recurrent implantation failure by one fixed number of embryo transfers for everyone. Instead, it suggests using the cumulative predicted chance of implantation to decide when further investigation is appropriate, with 60% proposed as a useful clinical threshold.

That matters because a first or second failed transfer is painful and frustrating, but it does not automatically mean the next step should be multiple immune treatments.

If you are already using IVIG, heparin or anticoagulants, clarify the purpose

Some IVF patients are offered several add-ons at once, such as IVIG, heparin, aspirin or other anticoagulation strategies. If dexamethasone is added on top, the key question is not simply whether another medication can be added. It is whether each medication has a clear role.

Ask whether dexamethasone is intended to:

1. replace another immune-suppressing treatment or be used in addition to it;
2. cover only the transfer and implantation window or continue after a positive pregnancy test;
3. target a specific repeated abnormality or simply add reassurance;
4. be tapered or stopped at a defined point if pregnancy occurs.

The last scenario, adding it because more treatment feels safer, deserves caution. Cochrane and ASRM both conclude that the current evidence for peri-implantation glucocorticoids is limited and does not prove better IVF outcomes. Reproductive immunology literature also warns that immune suppression may be harmful in some settings and that blind use of glucocorticoids remains a problem.

Risks to review before taking dexamethasone

Even if the plan is short term, dexamethasone is still a systemic steroid. Your fertility team needs to know your medical history and pregnancy plans before prescribing it.

MedlinePlus advises patients to tell their doctor if they have or have had liver, kidney, intestinal or heart disease; diabetes; an underactive thyroid; high blood pressure; mental illness; myasthenia gravis; osteoporosis; herpes eye infection; seizures; tuberculosis; or ulcers. It also advises telling the doctor if you are pregnant, planning pregnancy or breastfeeding.

Key risks to discuss include:

• Infection risk. MedlinePlus notes that dexamethasone can make people more susceptible to illness, and the FDA label warns of immunosuppression and increased risk of new, worsened, disseminated or reactivated infections.
• Blood sugar and endocrine effects. The FDA label states that chronic use can cause hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome and hyperglycaemia.
• Blood pressure and metabolic concerns. StatPearls notes that large doses have been associated with increased blood pressure, and a review of recurrent implantation failure literature highlights potential pregnancy-related concerns including gestational diabetes, hypertension and infection susceptibility.
• Pregnancy-specific considerations. StatPearls recommends caution with dexamethasone during pregnancy and mentions an increased risk of oral cleft formation. A recurrent implantation failure review also notes that dexamethasone can cross the placenta, raising clinical concerns about fetal immune and endocrine development.
• Contraindications and important history. The FDA label lists hypersensitivity to dexamethasone and systemic fungal infections as contraindications. Histories such as ulcers, tuberculosis or herpes eye infection should also be reviewed with a clinician before use.

Seven questions to ask your fertility doctor

If your doctor recommends dexamethasone before or after embryo transfer, bring the discussion down to specifics:

1. What is the exact goal of adding dexamethasone in my case? Is it aimed at cytokines, natural killer cells, Th1/Th2 findings or another clinical issue?
2. Is it replacing another immune treatment, or is it being added to IVIG, heparin, aspirin or anticoagulants?
3. What day do I start, and what day do I stop? Is the plan to stop at the pregnancy test or continue if it is positive?
4. If I continue after a positive test, until what week, and how will the dose be reduced or stopped?
5. What monitoring do I need? Ask specifically about blood sugar, blood pressure, infection symptoms and any personal stomach or ulcer history.
6. What should I do if I develop fever, sore throat, urinary symptoms, herpes symptoms or significant stomach pain? Dexamethasone is linked with increased infection-related risk, so you should know when to call and whom to contact.
7. Based on my transfer history, have I truly reached the point where immune escalation is justified? ESHRE recommends using cumulative predicted implantation probability to guide RIF investigation rather than relying only on a fixed transfer count.

Bottom line

For someone having a first or second embryo transfer, with no recurrent implantation failure, recurrent pregnancy loss or other clear clinical clues, the evidence does not support adding dexamethasone solely because one immune marker is abnormal.

For someone with multiple unsuccessful transfers, a work-up consistent with recurrent implantation failure and repeated immune or inflammatory findings, a short course may be a reasonable topic to discuss with a reproductive medicine specialist, provided the plan includes a clear rationale, alternatives and monitoring.

The practical bottom line: dexamethasone is not a harmless just-in-case add-on. It is a prescription steroid that needs a defined purpose, a defined time limit and a defined safety plan.